Okayama, Japan

Ichiro Fujiwara

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Ensuiko Sugar Refining Co., Ltd., Hiroki Hamada, Okayama University. Active years: 2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ichiro Fujiwara. Retrieved from https://idiyas.com/inventor/ichiro-fujiwara-dg4ohw7i

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ichiro Fujiwara: Innovator in Liposome Technology

Introduction

Ichiro Fujiwara is a notable inventor based in Okayama, Japan. He has made significant contributions to the field of pharmaceutical technology, particularly in the development of methods for producing liposomes that encapsulate paclitaxel derivatives. His work aims to enhance the efficacy of anti-cancer treatments while minimizing side effects.

Latest Patents

Ichiro Fujiwara holds a patent for a "Method for producing liposome encapsulating paclitaxel monoglycoside and/or docetaxel monoglycoside." This innovative method addresses the challenges associated with the poor introduction efficiency of paclitaxel derivatives into liposomes. The invention provides a practical solution by utilizing a specific combination of components to create liposomes that can effectively deliver these anti-cancer agents.

Career Highlights

Throughout his career, Ichiro Fujiwara has worked with various companies, including Ensuiko Sugar Refining Co., Ltd. and Hiroki Hamada. His experience in these organizations has contributed to his expertise in pharmaceutical innovations and liposome technology.

Collaborations

Ichiro has collaborated with notable individuals in his field, including Hiroki Hamada and Masaharu Seno. These partnerships have facilitated advancements in his research and development efforts.

Conclusion

Ichiro Fujiwara's contributions to liposome technology represent a significant advancement in the field of cancer treatment. His innovative methods have the potential to improve the effectiveness of anti-cancer drugs while reducing adverse effects.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…